Search Results

There are 420031 results for: content related to: Double Blind Comparison of Lithium and Verapamil in Cluster Headache Prophylaxis

  1. Cluster Headache

    European Handbook of Neurological Management

    S. Evers, J. Áfra, A. Frese, P. J. Goadsby, M. Linde, A. May, P. S. Sándor, Pages: 177–190, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch14

  2. You have free access to this content
    Abstracts

    Cephalalgia

    Volume 29, Issue s1, October 2009, Pages: 1–166,

    Version of Record online : 11 SEP 2009, DOI: 10.1111/j.1468-2982.2009.01960.x

  3. Verapamil Hydrochloride: Pharmacological Properties and Role in Cardiovascular Therapeutics

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 2, Issue 6, November-December 1982, Pages: 328–350, Ms. Sherrin H. Baky and Dr. Bramah N. Singh

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1982.tb03210.x

  4. You have free access to this content
    Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 78, Issue 6, December 2014, Pages: 1426–1432, Sung Kweon Cho, Choon Ok Kim, Eun Seok Park and Jae-Yong Chung

    Version of Record online : 20 NOV 2014, DOI: 10.1111/bcp.12476

  5. Cluster Headache and Other Trigemino-Autonomic Cephalgias

    European Handbook of Neurological Management, Second Edition, Volume 1, Second Edition

    S. Evers, J. Áfra, A. Frese, P. J. Goadsby, M. Linde, A. May, P. S. Sándor, Pages: 179–190, 2010

    Published Online : 6 SEP 2010, DOI: 10.1002/9781444328394.ch11

  6. Profibrillatory Effects of Verapamil but Not of Digoxin in the Goat Model of Atrial Fibrillation

    Journal of Cardiovascular Electrophysiology

    Volume 11, Issue 12, December 2000, Pages: 1375–1385, MATTIAS F. DUYTSCHAEVER, CLIFFORD J. GARRATT and MAURITS A. ALLESSIE

    Version of Record online : 28 JUN 2008, DOI: 10.1046/j.1540-8167.2000.01375.x

  7. You have free access to this content
    The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel

    British Journal of Pharmacology

    Volume 127, Issue 5, July 1999, Pages: 1065–1074, Heiko Rauer and Stephan Grissmer

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0702599

  8. You have free access to this content
    Non-linear pharmacokinetics of high-dose intravenous verapamil

    British Journal of Clinical Pharmacology

    Volume 44, Issue 3, September 1997, Pages: 255–260, G. Toffoli, I. Robieux, D. Fantin, M. Gigante, S. Frustaci, G. L. Nicolosi, M. De Cicco and M. Boiocchi

    Version of Record online : 2 OCT 2003, DOI: 10.1046/j.1365-2125.1997.t01-1-00574.x

  9. No Effect of High-Protein Food on the Stereoselective Bioavailability and Pharmacokinetics of Verapamil

    The Journal of Clinical Pharmacology

    Volume 36, Issue 11, November 1996, Pages: 1022–1028, Dr. Masayuki Hashiguchi, Dr. Hiroyasu Ogata, Dr. Akira Maeda, Ms. Ms. Yuka Hirashima, Ms. Ms. Shizuka Ishii, Ms. Ms. Yuko Mori, Dr. Toshiaki Amamoto, Dr. Toshiya Handa, Mr. Norio Otsuka, Dr. Shin Irie, Dr. Akinori Urae, Dr. Ryuji Urae and Mr. Ryoji Kimura

    Version of Record online : 8 MAR 2013, DOI: 10.1177/009127009603601106

  10. Verapamil increases serum alkaline phosphatase in hypertensive patients

    Journal of Internal Medicine

    Volume 228, Issue 4, October 1990, Pages: 339–342, G. SJÖDÉN, M. ROSENQVIST, E. KRIEGHOLM, J. NORDENSTRÖM and I. BJÖRKHEM

    Version of Record online : 4 AUG 2009, DOI: 10.1111/j.1365-2796.1990.tb00242.x

  11. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: An investigation comparing single and multiple dosing

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 5, May 2001, Pages: 324–332, Dagmar Busse, Martin F. Fromm, Klaus Mörike, Siegfried Drescher, Volker Kühlkamp and Michel Eichelbaum

    Version of Record online : 2 MAY 2001, DOI: 10.1067/mcp.2001.115125

  12. Antiarrhythmic Action of Verapamil: Comparison to Other Calcium Channel Antagonists

    Journal of Cardiovascular Electrophysiology

    Volume 2, Issue 1, February 1991, Pages: 24–42, JAMES V. TALANO

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1540-8167.1984.tb01641.x

  13. Comprehensive cytotoxic evaluation of morin, a bioflavonoid against verapamil on rat gastrointestinal epithelium for novel pharmaceutical application involving P-glycoprotein inhibition

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 8, August 2015, Pages: 1083–1099, Gurunath Surampalli, Basavaraj K. Nanjwade and Paragouda A. Patil

    Version of Record online : 13 APR 2015, DOI: 10.1111/jphp.12400

  14. You have free access to this content
    Application of permeability-limited physiologically-based pharmacokinetic models: Part II - prediction of p-glycoprotein mediated drug–drug interactions with digoxin

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 9, September 2013, Pages: 3161–3173, Sibylle Neuhoff, Karen Rowland Yeo, Zoe Barter, Masoud Jamei, David B. Turner and Amin Rostami-Hodjegan

    Version of Record online : 19 MAY 2013, DOI: 10.1002/jps.23607

  15. Comparison of Intravenous Diltiazem and Verapamil for the Acute Treatment of Atrial Fibrillation and Atrial Flutter

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 6, November-December 1997, Pages: 1238–1245, Bradley G. Phillips, Ashesh J. Gandhi, Cynthia A. Sanoski, Vicki L. Just and Jerry L. Bauman

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03087.x

  16. You have free access to this content
    Verapamil disposition-effects of sulphinpyrazone and cimetidine.

    British Journal of Clinical Pharmacology

    Volume 19, Issue 3, March 1985, Pages: 385–391, LM Wing, JO Miners and KJ Lillywhite

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1985.tb02658.x

  17. You have free access to this content
    The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.

    British Journal of Clinical Pharmacology

    Volume 25, Issue 3, March 1988, Pages: 349–357, JC McCourty, JH Silas, GT Tucker and MS Lennard

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1988.tb03313.x

  18. You have free access to this content
    Competitive and Non-Competitive Inhibition of the Multidrug-Resistance-Associated P-glycoprotein ATPase

    European Journal of Biochemistry

    Volume 244, Issue 2, March 1997, Pages: 664–673, Manuel Garrigos, Lluis M. Mir and Stéphane Orlowski

    Version of Record online : 16 JUL 2004, DOI: 10.1111/j.1432-1033.1997.00664.x

  19. Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 12, December 2008, Pages: 5386–5400, Stina Syvänen, Andrew Hooker, Obaidur Rahman, Helena Wilking, Gunnar Blomquist, Bengt Långström, Mats Bergström and Margareta Hammarlund-Udenaes

    Version of Record online : 2 APR 2008, DOI: 10.1002/jps.21359

  20. INHIBITORY EFFECTS OF VERAPAMIL ON [3H]-ACETYLCHOLINE RELEASE IN THE CENTRAL NERVOUS SYSTEM OF SPRAGUE-DAWLEY RATS

    Clinical and Experimental Pharmacology and Physiology

    Volume 21, Issue 7, July 1994, Pages: 527–531, Kazushi Tsuda, Seiko Tsuda, Menek Goldstein and Yoshiaki Masuyama

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-1681.1994.tb02551.x